Oncologic outcomes of adjuvant chemotherapy in patients with risk factors after radical surgery in FIGO stage IB–IIA cervical cancer

2017 ◽  
Vol 145 ◽  
pp. 8-10
Author(s):  
K.B. Lee ◽  
J.M. Lee ◽  
Y.S. Kim
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Adjuvant Chemotherapy ◽  
Radical Surgery ◽  
Figo Stage ◽  
Oncologic Outcomes ◽  
Stage Ib

Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB–IIA cervical cancer

2008 ◽  
Vol 18 (5) ◽  
pp. 1027-1031 ◽  
Author(s):  
K.-B. Lee ◽  
J.-M. Lee ◽  
K.-D. Ki ◽  
S.-K. Lee ◽  
C.-Y. Park ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Adjuvant Chemotherapy ◽  
Tumor Size ◽  
Resection Margin ◽  
Figo Stage ◽  
Uterine Cervical Cancer ◽  
Intermediate Risk ◽  
Stromal Invasion ◽  
Stage Ib

The aim of this study was to compare the outcome of chemotherapy or radiation as adjuvant therapy for patients with FIGO stage IB–IIA cervical cancer and surgically confirmed intermediate risk factors. Data were collected from patients with uterine cervical cancer FIGO stage IB–IIA who had adjuvant chemotherapy following radical hysterectomy with pelvic lymph node dissection (RHLND, cases) or adjuvant radiotherapy following RHLND (controls). The study groups consisted of 38 cases and 42 controls. Adjuvant treatment was given to the patients with a combination of intermediate risk factors including deep stromal invasion (>50%), lymphvascular space invasion, large tumor size (3–6 cm), or close vaginal resection margin (<1 cm). Comparison of the cases with the controls revealed no significant differences in variables studied including median age (P= 0.18), stage distribution (P= 0.30), histologic subtype (P= 0.93), pathologic tumor size (P= 0.46), depth of the stromal invasion (P= 0.29), lymphvascular space invasion (P= 0.50), and close vaginal resection margin (P= 0.62). The difference in disease-free survival rates was not significant (P= 0.68). However, the overall survival analysis was incomplete due to the limited number of events available at the end of the study period. The findings of this study suggest that adjuvant chemotherapy in patients with FIGO stage IB–IIA uterine cervical cancer and surgically confirmed intermediate risk factors may be effective.

Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB–IIA Cervical Cancer

2017 ◽  
Vol 27 (8) ◽  
pp. 1722-1728 ◽  
Author(s):  
Emel Canaz ◽  
Eser Sefik Ozyurek ◽  
Baki Erdem ◽  
Merve Aldikactioglu Talmac ◽  
Ipek Yildiz Ozaydin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Figo Stage ◽  
Stage Ib ◽  
Parametrial Involvement

P1090 Grouping of intermediate risk factors in FIGO stage IB-IIA postoperative cervical cancer

2009 ◽  
Vol 107 ◽  
pp. S717-S717
Author(s):  
S. Ryu ◽  
S. Park ◽  
K. Kim ◽  
B. Kim ◽  
M. Kim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Figo Stage ◽  
Intermediate Risk ◽  
Stage Ib

Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgery

2016 ◽  
Vol 43 (1) ◽  
pp. 211-219 ◽  
Author(s):  
Soyi Lim ◽  
Kyungjoo Cho ◽  
Seungho Lee ◽  
Kwangbeom Lee ◽  
Jinwoo Shin ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Lymph Nodes ◽  
Cancer Patients ◽  
Radical Surgery ◽  
Figo Stage ◽  
Primary Radical ◽  
Stage Ib
Sign in / Sign up

Export Citation Format

Share Document